Megakaryon Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $25.6M
Latest Deal Amount
  • Investors
  • 16

Megakaryon General Information


Developer of blood cells' production technology created to promote the application of platelet techniques to clinical use. The company's technology specializes in the development of transfusion medicine for the production of red blood cells and platelets by using iPS cells, enabling medical practitioners with platelet products to maintain the platelet count in the patient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Primary Office
  • 134 Chudoji Minamimachi
  • Shimogyo-ku, Research Park Building No. 2
  • Kyoto, 600-8813
  • Japan
+81 000-000-0000

Megakaryon Timeline

Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Megakaryon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 17-Feb-2020 $25.6M 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 04-Jan-2018 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 23-Mar-2015 $20.8M $37.1M Completed Startup
1. Early Stage VC (Series A) 26-Aug-2013 $16.4M $16.4M Completed Startup
To view Megakaryon’s complete valuation and funding history, request access »

Megakaryon Executive Team (6)

Name Title Board Seat Contact Info
Kenichi Akamatsu Ph.D Chief Operating Officer, Chief Executive Officer and President
Tsuyoshi Ayabe Chief Financial Officer & Board Member
Koichi Samizo Ph.D Chief Strategy Officer & Board Member
Yoshihiro Kumagae Ph.D Chief Technology Officer & Senior Executive Officer
Tomoyuki Inoue Ph.D Executive Officer & Head of CMC
You’re viewing 5 of 6 executive team members. Get the full list »

Megakaryon Board Members (3)

Name Representing Role Since
Koichi Ashida Megakaryon Board Member 000 0000
Koichi Samizo Ph.D Megakaryon Chief Strategy Officer & Board Member 000 0000
Tsuyoshi Ayabe Megakaryon Chief Financial Officer & Board Member 000 0000
To view Megakaryon’s complete board members history, request access »

Megakaryon Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Satake Chemical Equipment Corporation Minority 000 0000 000000 0
SBI Investment Venture Capital Minority 000 0000 000000 0
Sekisui Chemical PE-Backed Company Minority 000 0000 000000 0
Otsuka Pharmaceutical Corporation Minority 000 0000 000000 0
Otsuka Pharmaceutical Factory Corporation Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »